Know LabsKNW
Market Cap: $28.4M
About: Know Labs Inc is a medical diagnostic. The company is focused on the development, marketing, and sales of proprietary technologies that are capable of uniquely identifying or authenticating almost any substance or material using electromagnetic energy to record, detect, and identify the signature of the substance or material known as Bio-RFID and ChromaID technologies. It is developing a wearable device that will measure blood glucose without fingersticks or microneedles.
Employees: 15
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
11% more funds holding
Funds holding: 28 [Q1] → 31 (+3) [Q2]
5% more capital invested
Capital invested by funds: $1.69M [Q1] → $1.78M (+$88.2K) [Q2]
1.77% more ownership
Funds ownership: 3.29% [Q1] → 5.06% (+1.77%) [Q2]
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
Research analyst outlook
We haven’t received any recent analyst ratings for KNW.
Financial journalist opinion
Based on 3 articles about KNW published over the past 30 days